KRT18 and COVID-19: K18-hACE2 transgenic mouse developed by McCray et al. for SARS-CoV studies along with tobacco smoke exposure rodent models could be useful available animal models for studying pathogenesis of SARS-CoV-2 and evaluating the impact of smoking and vaping on cerebrovascular and neurological dysfunction in COVID-19 patients [147,148].